ciprofloxacin has been researched along with gsk299423 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apicella, C; Corso, G; D'Atanasio, N; Di Giorgio, FP; Furlotti, G; Garofalo, B; Magarò, G; Mangano, G; Ombrato, R; Prati, F; Robinson, D | 1 |
| Bax, BD; Brown, KK; Chan, PF; Eggleston, DS; Fosberry, A; Gentry, DR; Giordano, I; Gorrec, F; Gwynn, MN; Hann, MM; Hennessy, A; Hibbs, M; Huang, J; Jones, E; Jones, J; Lewis, CJ; May, EW; Pearson, ND; Saunders, MR; Shen, C; Shillings, A; Singh, O; Spitzfaden, CE; Theobald, AJ; Wohlkonig, A | 1 |
2 other study(ies) available for ciprofloxacin and gsk299423
| Article | Year |
|---|---|
Virtual Screening Approach and Investigation of Structure-Activity Relationships To Discover Novel Bacterial Topoisomerase Inhibitors Targeting Gram-Positive and Gram-Negative Pathogens.
Topics: Amino Acid Sequence; Bacterial Infections; DNA Gyrase; DNA Topoisomerase IV; Escherichia coli; Microbial Sensitivity Tests; Models, Chemical; Molecular Structure; Sequence Homology, Amino Acid; Staphylococcus aureus; Structure-Activity Relationship; Topoisomerase Inhibitors | 2019 |
Type IIA topoisomerase inhibition by a new class of antibacterial agents.
Topics: Anti-Bacterial Agents; Apoenzymes; Arginine; Aspartic Acid; Binding Sites; Catalytic Domain; Ciprofloxacin; Crystallography, X-Ray; DNA; DNA Cleavage; DNA Gyrase; DNA, Superhelical; Drug Design; Drug Resistance; Escherichia coli; Manganese; Models, Molecular; Protein Conformation; Quinolines; Quinolones; Staphylococcus aureus; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2010 |